Tasly Pharma Gains NMPA Green Light for CAR-T Therapy Clinical Study in Recurrent Glioblastoma
China-based Tasly Pharma Co., Ltd (SHA: 600535) has announced that it has received approval from...
China-based Tasly Pharma Co., Ltd (SHA: 600535) has announced that it has received approval from...
China-based Tasly Pharma Co., Ltd (SHA: 600535) announced receiving approval from the National Medical Products...
China-based CR Sanjiu (SHE: 000999), a state-owned pharmaceutical company, has received approval from the State-owned...
China-based Tasly Pharma Co., Ltd (SHA: 600535) has announced that it has received marketing approval...
China-based Tasly Pharmaceuticals (SHA: 600535) has announced that it has received approval from the US...
China’s state-owned pharmaceutical company, CR Sanjiu (SHE: 000999), has announced its intention to conditionally purchase...
Tasly Pharmaceuticals (SHA: 600535), a leading pharmaceutical company in China, has announced that it has...
Tasly Pharmaceuticals (SHA: 600535), a China-based pharmaceutical company, has announced that it has received approval...
China-based Tasly Pharmaceuticals (SHA: 600535) has announced that it has received approval from the National...
China-based Tasly Pharmaceuticals (SHA: 600535) has announced that it has received approval from the National...
China-based Tasly Pharmaceuticals (SHA: 600535) announced a joint venture (JV) with France’s Mauna Kea Technologies...